USPTO serial 79049498
NAT-PURE
Reviewed by CopyMark Law Group
Reg. 3661026Status 404
- Filing date
- Status date
- Registration date
- Jul 28, 2009
- Examiner
- HAMPTON, CHARISMA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NAT-PURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products, namely, biomedical compounds in the nature of peptide substrates used in analyzing and detecting certain toxins, preservatives, plant food, and reagents extracted from living organisms for industrial, scientific, photographic, agricultural, horticultural and forestry purposes, and for analysis and synthesis purposes; ingredients for foodstuffs, namely, fermentation extracts, carbohydrates used as an ingredient or as an integral component in nutraceuticals, and sugar-free artificial sweeteners for beverages; additives for foodstuffs, namely, preservatives and stabilizers; fragrances for use in manufacturing of food | SECTION 71 - CANCELLED | — |
| 003 | Flavourings, namely, food flavorings prepared from essential oils; fragrances; flavour enhancers, namely, essential oils for food flavorings and essential oils for flavoring beverages | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical products for ophthalmological use, for treating respiratory diseases and asthma, and for the treatment of joint diseases; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes,and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the prevention and treatment of bacteria-based diseases for medical purposes; veterinary products, namely, pharmaceutical products for skin care for animals, animal feed supplements, nutritional drinks for animals, nutritional additives to foodstuffs for animals, for medical purposes; veterinary preparations for prevention and treatment of gastro-intestinal parasites, skin and coat parasites, parasitic worms, and claw disorders in livestock and campaign animals; dietetic food adapted for medical use; disinfectants for sanitary purposes, medical instruments, hygienic purposes; preparations for destroying vermin; pesticides; fungicides; herbicides; food additives, namely, nutritional additives to foodstuffs for animals, for medical purposes, nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; food supplements | SECTION 71 - CANCELLED | — |
| 042 | Scientific and industrial research, namely, pharmaceutical research and development of biologically active products and pharmaceutical products; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff in the field of foodstuff ingredients, foodstuff additives, and ingredients for cosmetics; computer centre services, namely, compiling data for research purposes in the field of medical science and medical consultancy; services in the field of chemistry information technology, namely, chemical research and analysis in the field of optimisation of key structures | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by InterMed Discovery GmbH
- Other trademarks owned by InterMed Discovery GmbH
- Other trademarks owned by InterMed Discovery GmbH
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named NAT-PURE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 20, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jul 20, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 28, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 11, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 11, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 4, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 4, 2016 | C71T | CANCELLED SECTION 71 | — |
| Jan 27, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 5, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 5, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 28, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 28, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 12, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 8, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 7, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 25, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 24, 2009 | PAPER RECEIVED | — | |
| Sep 25, 2008 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 24, 2008 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 9, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 9, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 9, 2008 | ALIE | ASSIGNED TO LIE | — |
| Aug 29, 2008 | PAPER RECEIVED | — | |
| May 3, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 31, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 31, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 29, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 28, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 7, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 6, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |